Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her ...

The latest from the BIO 2025 conference: more universities open to private equity deals, emerging companies turn to new ...

This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income ...

Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...

Tennessee’s ban on gender-affirming care for minors can stand after the Supreme Court ruled that it does not constitute ...

HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his ...

A U.K. health agency said the Alzheimer's drugs Kisunla and Leqembi are not cost-effective, meaning they won't be offered through the NHS.

“Using a common-sense approach, the national priority review program will allow companies to submit the lion’s share of the ...

The updated agenda for the Advisory Committee on Immunization Practices comes a week after Kennedy announced he had dismissed ...

Scholar Rock said its investigational therapy helped preserve lean mass among patients taking a powerful weight loss drug.